Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOP-14 plus Sargramostim in DLBCL
NCT00599170Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Jan 2008
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in diffuse large B-cell lymphoma (DLBCL), sponsored by University of Southern California. Started Jan 2008; status: completed.
02
Drugs
sargramostim
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00599170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599170.